The Journal of Urology
Volume 177, Issue 6 , Pages 2141-2145, June 2007

A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer

  • Michael Krainer

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationCorrespondence: Department of Medicine I and Cancer Center, Medical University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria (telephone: +43-1-40400-4449; FAX: +43-1-40400-4451).
  • ,
  • Sandra Tomek

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
  • ,
  • Katarzyna Elandt

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
  • ,
  • Peter Horak

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
  • ,
  • Walter Albrecht

      Affiliations

    • Department of Urology, Rudolfstiftung Hospital, Vienna, Austria
  • ,
  • Michael Eisenmenger

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
  • ,
  • Wolfgang Höltl

      Affiliations

    • Department of Urology, Kaiser-Franz-Josef Hospital, Vienna, Austria
  • ,
  • Paul Schramek

      Affiliations

    • Department of Urology, Barmherzige Bruder Hospital, Vienna, Austria
  • ,
  • Walter Stackl

      Affiliations

    • Department of Urology, Rudolfstiftung Hospital, Vienna, Austria
  • ,
  • Christoph Zielinski

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria
  • ,
  • Jochen Reibenwein

      Affiliations

    • Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, Vienna, Austria

Received 10 November 2006

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(07)00286-8

doi:10.1016/j.juro.2007.01.148

The Journal of Urology
Volume 177, Issue 6 , Pages 2141-2145, June 2007